Another double‐stain study showed similar results, in which Ki67/MART1 double staining misclassified 4.1% of melanomas and 7.7% of nevi and reported a low cut‐off value of 1.6% for the Ki67/MART1 index [46]. The gene discussed is MLANA; the disease is melanoma.